|
|
|
|
Linus Pauling Institute, Oregon State University, Corvallis, OR 97331
2To whom correspondence should be addressed. E-mail: Balz.Frei{at}oregonstate.edu.
Tea is particularly rich in polyphenols, including catechins, theaflavins and thearubigins, which are thought to contribute to the health benefits of tea. Tea polyphenols act as antioxidants in vitro by scavenging reactive oxygen and nitrogen species and chelating redox-active transition metal ions. They may also function indirectly as antioxidants through 1) inhibition of the redox-sensitive transcription factors, nuclear factor-
B and activator protein-1; 2) inhibition of "pro-oxidant" enzymes, such as inducible nitric oxide synthase, lipoxygenases, cyclooxygenases and xanthine oxidase; and 3) induction of phase II and antioxidant enzymes, such as glutathione S-transferases and superoxide dismutases. The fact that catechins are rapidly and extensively metabolized emphasizes the importance of demonstrating their antioxidant activity in vivo. Animal studies offer a unique opportunity to assess the contribution of the antioxidant properties of tea and tea polyphenols to the physiological effects of tea administration in different models of oxidative stress. Most promising are the consistent findings in animal models of skin, lung, colon, liver and pancreatic cancer that tea and tea polyphenol administration inhibit carcinogen-induced increases in the oxidized DNA base, 8-hydroxy-2'-deoxyguanosine. In animal models of atherosclerosis, green and black tea administration has resulted in modest improvements in the resistance of lipoproteins to ex vivo oxidation, although limited data suggest that green tea or green tea catechins inhibit atherogenesis. To determine whether tea polyphenols act as effective antioxidants in vivo, future studies in animals and humans should employ sensitive and specific biomarkers of oxidative damage to lipids, proteins and DNA.
KEY WORDS: tea polyphenol antioxidant biomarker oxidative damage
This article has been cited by other articles:
![]() |
J. L. Barranco Quintana, M. F. Allam, A. S. Del Castillo, and R. F.-C. Navajas Parkinson's Disease and Tea: A Quantitative Review J. Am. Coll. Nutr., February 1, 2009; 28(1): 1 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Shrubsole, W. Lu, Z. Chen, X. O. Shu, Y. Zheng, Q. Dai, Q. Cai, K. Gu, Z. X. Ruan, Y.-T. Gao, et al. Drinking Green Tea Modestly Reduces Breast Cancer Risk J. Nutr., February 1, 2009; 139(2): 310 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Kim, R. Rajaiah, Q.-L. Wu, S. R. Satpute, M. T. Tan, J. E. Simon, B. M. Berman, and K. D. Moudgil Green Tea Protects Rats against Autoimmune Arthritis by Modulating Disease-Related Immune Events J. Nutr., November 1, 2008; 138(11): 2111 - 2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kuriyama The Relation between Green Tea Consumption and Cardiovascular Disease as Evidenced by Epidemiological Studies J. Nutr., August 1, 2008; 138(8): 1548S - 1553S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Larsson, S. Mannisto, M. J. Virtanen, J. Kontto, D. Albanes, and J. Virtamo Coffee and Tea Consumption and Risk of Stroke Subtypes in Male Smokers Stroke, June 1, 2008; 39(6): 1681 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Bruno, C. E. Dugan, J. A. Smyth, D. A. DiNatale, and S. I. Koo Green Tea Extract Protects Leptin-Deficient, Spontaneously Obese Mice from Hepatic Steatosis and Injury J. Nutr., February 1, 2008; 138(2): 323 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-P. Hsu, M.-S. Wu, C.-C. Yang, K.-C. Huang, S.-Y. Liou, S.-M. Hsu, and C.-T. Chien Chronic green tea extract supplementation reduces hemodialysis-enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1539 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Carlson, B. A. Bauer, A. Vincent, P. J. Limburg, and T. Wilson Reading the Tea Leaves: Anticarcinogenic Properties of (-)-Epigallocatechin-3-Gallate Mayo Clin. Proc., June 1, 2007; 82(6): 725 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shapiro, P. Singer, Z. Halpern, and R. Bruck Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis Gut, March 1, 2007; 56(3): 426 - 436. [Full Text] [PDF] |
||||
![]() |
B. Wessner, E.-M. Strasser, N. Koitz, C. Schmuckenschlager, N. Unger-Manhart, and E. Roth Green Tea Polyphenol Administration Partly Ameliorates Chemotherapy-Induced Side Effects in the Small Intestine of Mice J. Nutr., March 1, 2007; 137(3): 634 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Fink, S. E. Steck, M. S. Wolff, J. A. Britton, G. C. Kabat, J. C. Schroeder, S. L. Teitelbaum, A. I. Neugut, and M. D. Gammon Dietary Flavonoid Intake and Breast Cancer Risk among Women on Long Island Am. J. Epidemiol., March 1, 2007; 165(5): 514 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stangl, H. Dreger, K. Stangl, and M. Lorenz Molecular targets of tea polyphenols in the cardiovascular system Cardiovasc Res, January 15, 2007; 73(2): 348 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Maeta, W. Nomura, Y. Takatsume, S. Izawa, and Y. Inoue Green Tea Polyphenols Function as Prooxidants To Activate Oxidative-Stress-Responsive Transcription Factors in Yeasts Appl. Envir. Microbiol., January 1, 2007; 73(2): 572 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kuriyama, T. Shimazu, K. Ohmori, N. Kikuchi, N. Nakaya, Y. Nishino, Y. Tsubono, and I. Tsuji Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA, September 13, 2006; 296(10): 1255 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Kim, M. A. Abdelmegeed, and R. F. Novak THE MITOGEN-ACTIVATED PROTEIN KINASE KINASE (MEK) INHIBITOR PD98059 ELEVATES PRIMARY CULTURED RAT HEPATOCYTE GLUTATHIONE LEVELS INDEPENDENT OF INHIBITING MEK Drug Metab. Dispos., April 1, 2006; 34(4): 683 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Larsson and A. Wolk Tea Consumption and Ovarian Cancer Risk in a Population-Based Cohort Arch Intern Med, December 12, 2005; 165(22): 2683 - 2686. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Buffoli, O. Pechanova, S. Kojsova, R. Andriantsitohaina, L. Giugno, R. Bianchi, and R. Rezzani Provinol Prevents CsA-induced Nephrotoxicity by Reducing Reactive Oxygen Species, iNOS, and NF-kB Expression J. Histochem. Cytochem., December 1, 2005; 53(12): 1459 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Yuan, W.-P. Koh, C.-L. Sun, H.-P. Lee, and M. C. Yu Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore Carcinogenesis, August 1, 2005; 26(8): 1389 - 1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Seely, E. J. Mills, P. Wu, S. Verma, and G. H. Guyatt The Effects of Green Tea Consumption on Incidence of Breast Cancer and Recurrence of Breast Cancer: A Systematic Review and Meta-analysis Integr Cancer Ther, June 1, 2005; 4(2): 144 - 155. [Abstract] [PDF] |
||||
![]() |
J. W. FINLEY Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds Ann. Bot., June 1, 2005; 95(7): 1075 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D Lambert, J. Hong, G.-y. Yang, J. Liao, and C. S Yang Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations Am. J. Clinical Nutrition, January 1, 2005; 81(1): 284S - 291S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Henning, Y. Niu, N. H Lee, G. D Thames, R. R Minutti, H. Wang, V. L. W Go, and D. Heber Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1558 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Sanderson, J. Hordijk, M. S. Denison, M. F. Springsteel, M. H. Nantz, and M. van den Berg Induction and Inhibition of Aromatase (CYP19) Activity by Natural and Synthetic Flavonoid Compounds in H295R Human Adrenocortical Carcinoma Cells Toxicol. Sci., November 1, 2004; 82(1): 70 - 79. [Abstract] [Full Text] [PDF] |
||||